Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 30, 2016Neurology Neuroimmunology & NeuroinflammationOpen Access

Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS

View Full Paper
Ask AI
Bookmark
Share

Authors

KTKatja ThomasJEJudith EiseleFRFrancisco Alejandro Rodriguez-Leal

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Thomas et al. (2016) studied this question.

synapsesocial.com/papers/6a6fa156c2d7c3090826cb13https://doi.org/10.1212/nxi.0000000000000228
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Accumulation and therapeutic modulation of 6-sulfo LacNAc + dendritic cells in multiple sclerosis2014 · 29 citations
  2. 2Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis1996 · 251 citations
  3. 3Ubiquitous Expression of the Calcitonin-I Gene in Multiple Tissues in Response to Sepsis<sup>1</sup>2001 · 441 citations
  4. 4Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy2014 · 241 citations
  5. 5Current concepts in the diagnosis and management of cytokine release syndrome2014 · 2,853 citations